By Editor , 17 September 2026

Suzhou – – September 16, 2026 -- Accro Bioscience said AC-101 tablets have been included in the National Medical Products Administration's Center for Drug Evaluation (CDE) "Caring Plan-Extension" pilot program, targeting Blau syndrome as the proposed indication, with the public notice period closing September 11, 2026.

By Editor , 17 September 2026
Whitehawk Data Show PTK7 Target Stable After Lung Cancer Treatment

Morristown, N.J. – September 16, 2026 -- Whitehawk Therapeutics (Nasdaq: WHWK) presented real-world data at the IASLC 2026 World Conference on Lung Cancer in Seoul showing that PTK7 expression remains stable in pretreated, EGFR wild-type non-small cell lung cancer (NSCLC), reinforcing the target biology behind its Phase 1 antibody-drug conjugate (ADC) HWK-007.

By Editor , 17 September 2026
Agog-Backed Immersive Works Win Two Top Prizes at Venice Festival

Los Angeles – September 16, 2026 -- Two immersive media projects supported by Agog: The Immersive Media Institute captured two of the three prizes awarded in the Venice Immersive competition at the 83rd Venice International Film Festival. Out of the Ashes, co-directed by Rory Mitchell and Nonny de la Peña, received the Venice Immersive Special Jury Prize, while Empire at Sea, created and directed by Peter Flaherty, earned the Venice Immersive Achievement Prize.

By Editor , 17 September 2026
Oracle's Ellison Cancels Stock Sale Plan, No Shares Sold

Austin, Texas – September 16, 2026 -- Oracle Corporation (NYSE: ORCL) confirmed that Executive Chair and Chief Technology Officer Larry Ellison has cancelled his 10b5-1 trading plan to sell company stock, halting a scheduled divestment before any shares changed hands.

Ellison cancels stock sale plan with zero shares sold

Oracle stated no stock was sold under the now-terminated 10b5-1 plan. The company added that Ellison currently has no other arrangements in place to sell any of his Oracle shares.

By Editor , 17 September 2026
Aignostics Launches PathoSearch, AI Visual Search for Pathology Cases

Berlin – September 16, 2026 -- Aignostics has opened early access to PathoSearch, a visual search engine that retrieves diagnosed reference pathology cases from a single screenshot of an H&E slide, targeting the rare and complex cases that make up as much as 20% of a pathologist's caseload.

By Editor , 17 September 2026

Boston – September 16, 2026 -- PerZeption Inc. has secured a Phase I Small Business Innovation Research (SBIR) grant from the National Eye Institute to fund development of a new photostress recovery test for age-related macular degeneration (AMD), a condition affecting an estimated 20 million people in the United States.

By Editor , 17 September 2026
ICW Group Joins 9/11 Day Effort to Pack 20 Million Meals Nationwide

San Diego – September 16, 2026 -- ICW Group Insurance Companies joined thousands of volunteers across the United States to help pack an estimated 20 million meals for people facing food insecurity, marking the 25th anniversary of Sept. 11 through a nationwide day of service organized by nonprofit 9/11 Day.

By Editor , 17 September 2026
Court Disqualifies HSF Kramer from Pleasants Power Station Bankruptcy Case

Wilmington, Del. – September 16, 2026 -- The U.S. Bankruptcy Court has disqualified law firm HSF Kramer from representing Pleasants Power Station in its Chapter 11 proceedings, sustaining conflict-of-interest objections raised by Omnis Fuel Technologies and the Office of the United States Trustee.